Plain-English translation of NCT07446491 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a medication called , given as a single shot under the skin, to help raise platelet counts in people with chronic liver disease. Low platelet counts can increase bleeding risk during medical procedures. Researchers want to see if this new treatment is safe and effective at raising platelet counts before elective procedures.
People with chronic liver disease often have dangerously low platelet counts, which makes medical procedures riskier because of increased bleeding. Current treatment options are limited, so this trial is exploring whether this medication can be a new, simpler option to prepare patients safely for necessary procedures.
You likely qualify if…
You likely don't qualify if…
The trial happens in two stages. In the first stage, small groups of patients receive increasing doses of the medication to test safety. In the second stage, you would receive either the medication or a placebo (dummy injection) and be monitored before your scheduled procedure. You'll have blood tests to check your platelet count and be evaluated for any side effects.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
China